StockAnalyzer

Financial Analysis

DashboardSectorsComparablesScreenerUniverseMicrocapsAI 2nd OrderTheme MapEnergy & MaterialsMacroWatchlistCompareMi CarteraPortfolio

Recent

v0.1
RAJNISH.BO$0.44-2.22%
Fair $0.44+0.0%

RAJNISH.BO

Rajnish Wellness Limited

Consumer Defensive / Household & Personal ProductsBSE

$0.44

-0.01 (-2.22%)

Fairly Valued+0.0%Fair Value $0.44Fund rank 24/100 · Data gapFallback financials|
SA 37/D
F-Score: 2/9
Low Profitability

FCF base 3Y

n/d

n/d CAGR · yield n/d

FCF base 5Y

n/d

n/d base · n/d expected

Precio de entrada

n/d

MOS 34% · confianza 18%

FCF escenarios

weak_data · normalized FCF $-42.5M · quality 43.7/100

Data gap 24/100
Bear 5Yn/dn/d
Base 5Yn/dn/d
Bull 5Yn/dn/d
Return 0/100Downside 20/100Model quality 6/100Data QA 20/100

Ranking barato/determinista: CAGR esperado 5Y + downside bear + calidad del modelo + balance + capital allocation + data gate. No entra en buy-candidate si la data es débil o el CAGR 5Y no compensa.

Quality + valuation scorecard

SA Score

37/100

D

Piotroski

2/9

balance/quality

Valuation

50/100

+0.0% upside

5Y CAGR

+0.0%

50/100

Data QA

16/100

SEC 0%

Latest source: unknownPeriods: 4Warnings: 1unknown: 4
No SEC-backed annual rows; valuation uses fallback financial data. Insufficient audited annual history (<3 SEC-backed years); composite fair value and forward targets are disabled until manually verified. ROE is 0.2%, below the 5% threshold
Thesis & Journal · RAJNISH.BOLocal privado en este navegador · Rajnish Wellness Limited
Plantilla tipo buy-side: tesis, bull/base/bear, catalizadores, riesgos, kill criteria y fecha de revisión. Esto no gasta GPT-5.5; luego lo usamos como contexto del memo.

Sin guardar todavía.

Market Cap

$447M

P/E

191.3x

↑

EV/EBITDA

62.7x

↑

ROE

0.2%

↓

Gross Margin

5.8%

↓

Debt/Equity

0.00

↓
52-Week Range$0
$0$1

TradingView lightweight chart

RAJNISH.BO price, volumen y niveles de valoración

Último $0.440Periodo -70.3%
Fair value: $0.440

Price & Ratios

Absolute Values (Left Axis)

Ratios / Percentages (Right Axis)

Financial statement dashboard

Crecimiento, márgenes y provenance

2022–2025 · 3 años de histórico normalizado

Revenue CAGR

+22.5%

FCF CAGR

—

FCF margin

-8.8%

FCF / Net income

-24.60x

Latest source

Provider fallback

Margin decomposition

Último año: revenue $485.6M · net income $1.7M · FCF $-42.5M

2022-FY → 2025-FY

Gross margin

5.8%-3.4% pts

Operating margin

0.3%+1.0% pts

Net margin

0.4%-1.1% pts

FCF margin

-8.8%-8.7% pts
MetricTTM
2025
2024
2023
2022
Income Statement
Revenue$485.6M$485.6M$766.8M$258.3M$264.4M
Net Income$1.7M$1.7M$10.3M$4.6M$3.9M
EBITDA$5.2M$5.2M$19.8M$6.8M$7.5M
EPS0.000.000.010.010.37
Gross Margin5.8%5.8%7.4%10.5%9.2%
Operating Margin0.3%0.3%4.3%-4.3%-0.7%
Net Margin0.4%0.4%1.3%1.8%1.5%
Balance Sheet
Debt/Equity0.000.000.060.120.41
Cash Flow
Free Cash Flow$-42.5M$-42.5M$16.6M$-621.1M$-118000.00
Returns
ROE0.2%0.2%1.2%0.6%1.8%
Valuation
P/E191.30191.30593.852826.678.26
EV/EBITDA62.7462.74312.581921.1115.14
P/B0.390.397.3115.670.15
Growth & Yield
Revenue Growth-36.7%-36.7%196.9%-2.3%—
EPS Growth-82.3%-82.3%116.7%-98.4%—

Revenue, Net Income & Free Cash Flow ($B)

Margins (%)

Returns (%)

Leverage & Liquidity

Reverse DCF · market-implied EPS growthterminal P/E 15.0x · COE 10.0%

3Y implied EPS CAGR

157.0%

muy exigente

EPS terminal req.

$0.04

Spread vs growth

-239.3%

5Y implied EPS CAGR

83.0%

muy exigente

EPS terminal req.

$0.05

Spread vs growth

-165.3%

10Y implied EPS CAGR

41.9%

muy exigente

EPS terminal req.

$0.08

Spread vs growth

-124.2%

Qué te dice: cuánto EPS CAGR está descontando el precio si sales al múltiplo terminal indicado. Si el growth observado queda por debajo, el mercado está pidiendo una ejecución muy fina.

Return attribution · 1Y approxreconcilia total -52.7%

Total return

-52.7%

Start / end P/E

71.5x → 191.3x

EPS bridge

0.01 → 0.00

Residual

-137.8%

EPS growth-82.3%
Multiple rerating+167.4%
Dividend+0.0%
Residual / FX / buybacks / cross-term-137.8%

Simple additive decomposition: total return = EPS growth contribution + P/E multiple contribution + dividend contribution + explicit residual. The residual captures cross-terms, buybacks/share-count effects, FX, special dividends, data noise and methodology mismatch so the bridge always reconciles.